The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma.
about
Predictors of optimal cytoreduction in patients with newly diagnosed advanced-stage epithelial ovarian cancer: Time to incorporate laparoscopic assessment into the standard of careDoes a standardized preoperative algorithm of clinical data improve outcomes in patients with ovarian cancer? A quality improvement projectA novel algorithm for the treatment strategy for advanced epithelial ovarian cancer: consecutive imaging, frailty assessment, and diagnostic laparoscopy.A Gynecologic Oncology Group Study of serum CA-125 levels in patients with stage III optimally debulked ovarian cancer treated with intraperitoneal compared to intravenous chemotherapy: an analysis of patients enrolled in GOG 172.Neoadjuvant chemotherapy in ovarian, primary peritoneal and tubal carcinoma: can imaging results prior to interval debulking predict survival?A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer.Usefulness of human epididymis protein 4 in predicting cytoreductive surgical outcomes for advanced ovarian tubal and peritoneal carcinoma.A framework for a personalized surgical approach to ovarian cancer.The use of CT findings to predict extent of tumor at primary surgery for ovarian cancer.Preoperative Lymphocyte-Monocyte Ratio Is a Predictor of Suboptimal Cytoreduction in Stage III-IV Epithelial Ovarian CancerSerum CA125 and HE4 levels as predictors for optimal interval surgery and platinum sensitivity after neoadjuvant platinum-based chemotherapy in patients with advanced epithelial ovarian cancerWhen should surgical cytoreduction in advanced ovarian cancer take place?Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial.Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.The role of surgery in the management of epithelial ovarian cancer.Prognostic and predictive value of CA-125 in the primary treatment of epithelial ovarian cancer: potentials and pitfalls.Standardized FDG uptake as a prognostic variable and as a predictor of incomplete cytoreduction in primary advanced ovarian cancer.Diffusion-weighted magnetic resonance imaging evaluation of intra-abdominal sites of implants to predict likelihood of suboptimal cytoreductive surgery in patients with ovarian carcinoma.CA-125 levels in predicting optimal cytoreductive surgery in patients with advanced epithelial ovarian carcinoma.Preoperative prediction of suboptimal resection in advanced ovarian cancer based on clinical and CT parameters.Model for Prediction of Optimal Debulking of Epithelial Ovarian Cancer
P2860
Q26828510-7AE64383-EA50-4C74-9560-E03F2F99DF63Q30945812-70C1CB78-968D-4312-9334-F4F5FD0ECA8CQ33900995-8C2542B3-FA63-4EAC-9371-BF0D6B3D5D9FQ35234443-0F7A74D9-1D50-4047-A148-127150AFC691Q35285340-BEA413EE-8BF4-4974-AA4E-5979CB35548EQ35294575-76E9A88F-13E1-49F3-BCA1-A718CCC13A32Q35812813-FF6EB0CC-1E89-4A04-B86B-F88F0CA83CEDQ35926352-959B4595-43A8-4A97-BCD6-330B67029F67Q37120222-6BB9F3BF-6902-458C-992D-0E0F825C4FE8Q37290454-EB3ED00A-3DC9-41E5-8403-D32BB9BCACB6Q37291762-F115111F-5B23-40B2-AB4C-32C19F826B3EQ37397877-40FD3A01-1E90-4BFD-9E31-1F96CC97A24EQ37400561-F49E49FF-5E12-4414-9179-770A19EECBB5Q37483443-E941C519-EE67-4A74-9AE9-D2D1206CC308Q37832930-5A557CE1-2F66-4B4C-BD10-7212B99511CAQ37977414-37F4702F-23E3-42C1-9A6A-4F93BCD6EE64Q39848816-5C539F87-49F8-4CC9-B4B3-4A9174ABEA70Q44770864-80348AAA-665F-41C4-86A8-A0E337CF61CAQ51052289-AA589F13-49B3-4EB3-A826-2ACCA36BA68FQ51628545-72E8EEDB-6D62-44CA-8432-F7629CC628DAQ55638402-D0B11A91-6353-4976-A736-89AA5DDB5638
P2860
The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The ability of preoperative se ...... epithelial ovarian carcinoma.
@ast
The ability of preoperative se ...... epithelial ovarian carcinoma.
@en
type
label
The ability of preoperative se ...... epithelial ovarian carcinoma.
@ast
The ability of preoperative se ...... epithelial ovarian carcinoma.
@en
prefLabel
The ability of preoperative se ...... epithelial ovarian carcinoma.
@ast
The ability of preoperative se ...... epithelial ovarian carcinoma.
@en
P2093
P356
P1433
P1476
The ability of preoperative se ...... epithelial ovarian carcinoma.
@en
P2093
P304
P356
10.1006/GYNO.2000.5749
P407
P577
2000-05-01T00:00:00Z